Home > Keywords > Thématique > Agenda

Agenda

Articles

  • FEDER
    16 March 2022, by Jonathan NOWAK

    Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
    Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)

  • Meet Vect-Horus at BIO Japan, October 8-10, 202
    19 September 2025, by Emmanuelle BETTENDORF

    We are excited to be attending BioJapan, taking place October 8-10.
    Our Senior Business Developer Faustine Ramel will be in Yokohama for the event – please let us know if you would like to schedule a meeting.
    https://jcd-expo.jp/en/

  • Meet Vect-Horus at BIO Europe Digital
    6 October 2020, by Elodie DORMES

    Emmanuelle BETTENDORF, Business Developer will attend BIO Europe from 26 – 29 October 2020 in a digital format.
    If you are interested to meet and discover VECTrans technology, please use the B2B Partnering system.

  • Vect-Horus will participate to the HealthTech Innovation Days on November 13-14, 2022
    11 October 2022, by Elodie DORMES

    Elodie DORMES, Business Development Manager, will attend the HealthTech Innovation Days in Paris on November 13-14, 2022.
    2 days dedicated to networking and interaction with Biotech and Pharmaceutical companies.

  • Vect-Horus will be attending the BiotechShowcase 23
    12 January 2023, by Elodie DORMES

    From January 18 to 19, Emmanuelle Bettendorf will participate in the virtual #BiotechShowcase at #JPM23 and will be available to e-meet with you on partnership opportunities.

  • e-Meet Vect-Horus at the digital BIO Europe Spring from March 28 to 31, 2022
    15 March 2022, by Elodie DORMES

    Emmanuelle BETTENDORF will participate in BioEurope Spring from March 28 to 31, 2022 and will be available to meet with you on partnership opportunities.

  • Vect-Horus will be attending BIO Europe from the 24th - 26th October in Germany
    20 October 2022, by Elodie DORMES

    This is the first in person BIOEurope since 2019 and we are excited to meet everyone face-to-face again.
    Feel free to connect with Emmanuelle BETTENDORF on the platform for a meeting/coffee to discuss our DrugDelivery platform, amongt others in Neurodegenerative, Muscular, Cardiovascular and Eye diseases.

  • Boulder Peptide Symposium
    28 January 2019, by Jonathan NOWAK

    VECT-HORUS to Present at Boulder Peptide Symposium 2015

  • Meet Vect-Horus at BIO Japan
    3 September 2019, by Elodie DORMES

    Dr Jamal TEMSAMANI, Drug Development and Corporate Director will attend BIO Japan from October 9–11, 2019
    If you are interested to meet, please use the B2B Partnering system.

  • Vect-Horus will be attending the EANM’19 Congress in Barcelona
    3 September 2019, by Elodie DORMES

    Cedric MALICET PhD, Oncology Project Manager and Elodie DORMES, Business Development Manager will attend EANM from 12-16 October, 2019 in Barcelona to discuss Peptide Receptor Radionuclide Therapy strategy and partnered Vect-Horus’ products.